Doorgaan naar hoofdnavigatie Doorgaan naar zoeken Ga verder naar hoofdinhoud

Role of DNA methylation in cardiovascular disease

  • Ugo Chianese
  • , Chiara Papulino
  • , Wout Megchelenbrink
  • , Lucia Scisciola
  • , Michelangela Barbieri
  • , Giuseppe Paolisso
  • , Lucia Altucci
  • , Rosaria Benedetti

Onderzoeksoutput: Hoofdstuk in Boek/Rapport/CongresprocedureHoofdstukpeer review

Samenvatting

This chapter explores on the role of epigenetic pathways in cardiovascular disease, with a particular focus on providing an overview of DNA methylation involvement. The text encompasses the biology and mechanics of DNA methylation process and its significance in the context of cardiovascular disease conditions. Numerous epidemiological studies reported DNA methylation as the principal risk factor that establishes a link between epigenomic components and the development of disease phenotypes. Methylation represents a fundamental step in the evolutionary trajectory of cardiovascular physiology, and this epigenetic alteration holds promise as both a predictive and diagnostic marker. Additionally, considering the potential to modulate epigenetic processes, this chapter underscores and elucidates the current and potential treatment strategies for cardiovascular disease at various stages, ranging from preclinical to clinical phases.

Originele taal-2Engels
TitelPharmacoepigenetics
UitgeverijElsevier
Pagina's903-918
Aantal pagina's16
ISBN van elektronische versie9780443187223
ISBN van geprinte versie9780443187230
DOI's
StatusGepubliceerd - 1 jan 2025

Vingerafdruk

Duik in de onderzoeksthema's van 'Role of DNA methylation in cardiovascular disease'. Samen vormen ze een unieke vingerafdruk.

Citeer dit